Tag: pharmaceutical analytical testing market trends

Uncover key drivers, emerging technologies, and competitive movements shaping the pharmaceutical analytical testing market from 2026–2035 with trusted insights from The Business Research Company

What level of CAGR-driven expansion is anticipated in the Pharmaceutical Analytical Testing Market between 2026 and 2030?

The pharmaceutical analytical testing market size has seen robust expansion in recent years. This market is set to expand from $8.21 billion in 2025 to $8.94 billion in 2026, exhibiting a compound annual growth rate (CAGR) of 8.9%. Factors contributing to its historical growth include the expansion of pharmaceutical manufacturing activities, increasing regulatory scrutiny on drug quality, growth in generic drug development, rising investments in R&D pipelines, and the expansion of global testing laboratory networks.

The pharmaceutical analytical testing market is projected to experience robust expansion over the coming years. This market is anticipated to reach $12.46 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 8.7%. Factors driving this growth during the forecast period include a heightened need for intricate biologics testing, a greater uptake of automated analytical platforms, the expansion of personalized medicine initiatives, an increased emphasis on accelerating regulatory approvals, and a growing dependence on contract testing organizations. Key trends anticipated during the forecast timeframe encompass a wider embrace of sophisticated analytical testing methods, an escalating demand for outsourced testing provisions, a reinforced commitment to regulatory-adherent testing procedures, an expansion in stability and bioanalytical testing, and an improved incorporation of automation within testing laboratories.

Access Your Free Sample Report for In-Depth Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=27378&type=smp

What Drivers Are Affecting Demand-Supply Dynamics In The Pharmaceutical Analytical Testing Market?

The escalating number of drug approvals and clinical trials is anticipated to drive the expansion of the pharmaceutical analytical testing market. This involves a regulated process of rigorously testing new medications for safety and effectiveness through clinical trials, followed by official authorization from health authorities for public availability. The increase in drug approvals and trials stems from advances in precision medicine, which facilitates the development of highly targeted therapies customized to individual genetic profiles, thereby improving their efficacy and prospects for regulatory success. Pharmaceutical analytical testing is vital for both drug approvals and clinical trials, as it ensures the safety, efficacy, and quality of pharmaceutical products by supplying validated data on stability, impurities, bioavailability, and pharmacokinetics, thereby supporting regulatory compliance and informed decision-making. For instance, in December 2024, the Association of the British Pharmaceutical Industry, a UK-based pharmaceutical industry trade body, reported that the total number of industry-sponsored clinical trials initiated in the United Kingdom rose from 411 in 2022 to 426 in 2023. Concurrently, Phase III trial initiations experienced a 16.5 percent growth over the same period, increasing from 182 to 212. Thus, the growing volume of drug approvals and trials is clearly stimulating the growth of the pharmaceutical analytical testing market.

What Segments Are Included Within The Pharmaceutical Analytical Testing Market?

The pharmaceutical analytical testing market covered in this report is segmented –

1) By Service Type: Bioanalytical Testing, Method Development And Validation, Stability Testing, Drug Substances Testing, Microbial Testing, Physical Characterization, Other Service Types

2) By Technique Used: Chromatography, Spectroscopy, Mass Spectrometry, Electrophoresis, Microscopy

3) By Application: Quality Control, Research And Development, Regulatory Compliance, Drug Approval And Registration, Post-Marketing Surveillance

4) By End User: Pharmaceutical Companies, Contract Research Organizations (CROs), Academic Institutions, Regulatory Bodies, Testing Laboratories

Subsegments:

1) By Bioanalytical Testing: Pharmacokinetics Testing, Biomarker Testing, Immunogenicity Testing, Toxicokinetics Testing

2) By Method Development And Validation: Analytical Method Development, Analytical Method Validation, Method Transfer

3) By Stability Testing: Long-Term Stability Testing, Accelerated Stability Testing, Stress Stability Testing, Photostability Testing

4) By Drug Substances Testing: Raw Material Testing, Intermediate Testing, Final Drug Substance Testing

5) By Microbial Testing: Bioburden Testing, Sterility Testing, Endotoxin Testing, Microbial Limit Testing

6) By Physical Characterization: Particle Size Analysis, Polymorphism Analysis, Rheology Testing, Thermal Analysis

7) By Other Service Types: Impurity Testing, Elemental Impurity Testing, Extractables And Leachables Testing, Packaging Testing

Which Trends Are Influencing The Development Of The Pharmaceutical Analytical Testing Market?

Leading companies in the pharmaceutical analytical testing market are concentrating on introducing novel solutions, such as digital reference materials platforms, to boost the precision, trackability, and effectiveness of laboratory testing processes. This approach aims to guarantee regulatory adherence and enhance overall data integrity. A digital reference materials platform is defined as an online or software-driven system that supplies authenticated, standardized digital datasets or models, which are used for calibrating, validating, and verifying analytical testing procedures within pharmaceutical laboratories. For instance, in November 2023, Merck Group, a Germany-based pharmaceutical company, unveiled ChemisTwin, the first-ever digital reference materials platform specifically designed for analytical testing. This platform automates the analysis of sample purity, compound identification, and degradation by utilizing calibrated, algorithm-based digital references. With digital signatures for over 1,500 reference materials, ChemisTwin streamlines and accelerates workflows in pharmaceutical quality control, quality assurance, and research and development by providing traceable digital records linked to physical reference materials. This innovative platform minimizes manual tasks like weighing and documentation, increases sampling rates, and refines the detection of sample inconsistencies, thereby ensuring the production of safer and more reliable products.

Who Are The Primary Competitors In The Global Pharmaceutical Analytical Testing Market?

Major companies operating in the pharmaceutical analytical testing market are Thermo Fisher Scientific Inc., Merck KGaA, IQVIA Holdings Inc., Laboratory Corporation of America Holdings, ICON Public Limited Company, Eurofins Scientific SE, Pharmaceutical Product Development LLC, WuXi AppTec Co. Ltd., Syneos Health Inc., Steris plc, Catalent Inc., Charles River Laboratories International Inc., Intertek Group plc, SGS Société Générale de Surveillance SA, Almac Group Limited, Pace Analytical Services LLC, Neotron S.p.A., Toxikon Corporation, Element Materials Technology Group Limited, Boston Analytical Inc., ALS Limited, Frontage Laboratories Inc.

Access The Complete Report For Deeper Market Insights:

https://www.thebusinessresearchcompany.com/report/pharmaceutical-analytical-testing-global-market-report

Which Global Regions Are Shaping The Competitive Landscape Of The Pharmaceutical Analytical Testing Market?

North America was the largest region in the pharmaceutical analytical testing market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the pharmaceutical analytical testing market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request Your Customized Pharmaceutical Analytical Testing Market Research Report for Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=27378&type=smp

Browse Through More Reports Similar to the Global Pharmaceutical Analytical Testing Market 2026, By The Business Research Company

Electric Light Commercial Vehicle Market Report 2026

https://www.thebusinessresearchcompany.com/report/electric-light-commercial-vehicle-global-market-report

Portable Power Stations Market Report 2026

https://www.thebusinessresearchcompany.com/report/portable-power-stations-global-market-report

Electric Lighting Equipment Market Report 2026

https://www.thebusinessresearchcompany.com/report/electric-lighting-equipment-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Uncover key drivers, emerging technologies, and competitive movements shaping the pharmaceutical analytical testing market from 2025–2034 with trusted insights from The Business Research Company

How Much Will The Pharmaceutical Analytical Testing Market Be Worth By 2029?

The pharmaceutical analytical testing market has experienced significant growth over recent years. Forecasts indicate it will increase from $7.52 billion in 2024 to reach $8.21 billion by 2025, demonstrating a compound annual growth rate (CAGR) of 9.1%. This historical growth is attributable to factors such as an increase in generic drug approvals, higher investment by pharmaceutical companies, the broadening of biologics and biosimilars, advancements in personalized medicine, and a growing need for advanced testing methodologies.

The pharmaceutical analytical testing market is projected to experience substantial expansion in the coming years. By 2029, its valuation is anticipated to reach $11.48 billion, demonstrating a compound annual growth rate (CAGR) of 8.7%. This projected growth for the forecast period stems from several factors, including an increasing need for biologics and cell and gene therapies, the expansion of pharmaceutical production facilities in developing regions, the growing intricacy of novel drug molecules, an uptick in the outsourcing of analytical services to contract research organizations (CROs), and an expanding portfolio of orphan and rare disease medications. Key trends predicted for this period encompass the integration of artificial intelligence for data interpretation, the implementation of real-time release testing (RTRT), the deployment of automation and robotics within quality control laboratories, the utilization of cloud-based laboratory information management systems, a broader embrace of automation and digitalization, and the incorporation of real-time analytics.

Get A Free Sample Of The Report:

https://www.thebusinessresearchcompany.com/sample.aspx?id=27378&type=smp

What Market Forces Are Contributing To The Growth Of The Pharmaceutical Analytical Testing Market?

The pharmaceutical analytical testing market is expected to grow due to the increasing number of drug approvals and trials. These encompass the regulated process of assessing new medications for their safety and effectiveness through clinical trials, followed by official authorization from health authorities for public use. The rise in drug approvals and trials is attributed to the progression of precision medicine, which facilitates the development of highly targeted therapies customized to individual genetic profiles, thereby enhancing their likelihood of efficacy and regulatory success. Pharmaceutical analytical testing is vital for both drug approvals and clinical trials, as it guarantees the safety, efficacy, and quality of drug products by offering validated data on aspects such as stability, impurities, bioavailability, and pharmacokinetics, thereby supporting regulatory compliance and informed decision-making. For example, in November 2023, a report from the Association of the British Pharmaceutical Industry (ABPI), a UK-based non-profit association, revealed that the total number of industry clinical trials initiated annually in the UK saw a minor increase of 4.3%, climbing from 394 trials in 2021 to 411 in 2022. As a result, the expanding volume of drug approvals and trials is a key driver for the pharmaceutical analytical testing market.

Which Segments Define The Structure Of The Pharmaceutical Analytical Testing Market?

The pharmaceutical analytical testing market covered in this report is segmented

1) By Service Type: Bioanalytical Testing, Method Development And Validation, Stability Testing, Drug Substances Testing, Microbial Testing, Physical Characterization, Other Service Types

2) By Technique Used: Chromatography, Spectroscopy, Mass Spectrometry, Electrophoresis, Microscopy

3) By Application: Quality Control, Research And Development, Regulatory Compliance, Drug Approval And Registration, Post-Marketing Surveillance

4) By End User: Pharmaceutical Companies, Contract Research Organizations (CROs), Academic Institutions, Regulatory Bodies, Testing Laboratories

Subsegments:

1) By Bioanalytical Testing: Pharmacokinetics Testing, Biomarker Testing, Immunogenicity Testing, Toxicokinetics Testing

2) By Method Development And Validation: Analytical Method Development, Analytical Method Validation, Method Transfer

3) By Stability Testing: Long-Term Stability Testing, Accelerated Stability Testing, Stress Stability Testing, Photostability Testing

4) By Drug Substances Testing: Raw Material Testing, Intermediate Testing, Final Drug Substance Testing

5) By Microbial Testing: Bioburden Testing, Sterility Testing, Endotoxin Testing, Microbial Limit Testing

6) By Physical Characterization: Particle Size Analysis, Polymorphism Analysis, Rheology Testing, Thermal Analysis

7) By Other Service Types: Impurity Testing, Elemental Impurity Testing, Extractables And Leachables Testing, Packaging Testing

What Strategic Shifts And Innovations Are Influencing The Pharmaceutical Analytical Testing Market?

Major companies operating in the pharmaceutical analytical testing market are prioritizing the introduction of innovative solutions, such as digital reference materials platforms, to boost the accuracy, traceability, and efficiency of laboratory testing processes, thereby ensuring regulatory compliance and elevating overall data integrity. A digital reference materials platform refers to an online or software-based system that provides authenticated, standardized digital datasets or models, which are utilized for calibrating, validating, and verifying analytical testing processes in pharmaceutical laboratories. For instance, in November 2023, Merck Group, a Germany-based pharmaceutical company, launched ChemisTwin, the first-ever digital reference materials platform designed for analytical testing that automates the analysis of sample purity, compound identification, and degradation using calibrated, algorithm-based digital references. Featuring digital signatures for over 1,500 reference materials, ChemisTwin optimizes and accelerates workflows in pharmaceutical quality control, quality assurance, and research and development by providing traceable digital records linked to physical reference materials. This innovative platform reduces manual tasks such as weighing and documentation, enhances sampling rates, and improves the detection of sample inconsistencies, thereby ensuring safer and more reliable products.

Which Firms Are Making The Biggest Impact In The Pharmaceutical Analytical Testing Market?

Major companies operating in the pharmaceutical analytical testing market are Thermo Fisher Scientific Inc., Merck KGaA, IQVIA Holdings Inc., Laboratory Corporation of America Holdings, Ajinomoto Co. Inc., ICON Public Limited Company, Eurofins Scientific SE, Pharmaceutical Product Development LLC, WuXi AppTec Co. Ltd., Syneos Health Inc., Steris plc, Catalent Inc., Charles River Laboratories International Inc., Intertek Group plc, AptarGroup Inc., West Pharmaceutical Services Inc., SGS Société Générale de Surveillance SA, Almac Group Limited, Pace Analytical Services LLC, Neotron S.p.A., Toxikon Corporation, Element Materials Technology Group Limited, and Boston Analytical Inc.

Access The Complete Report Here:

https://www.thebusinessresearchcompany.com/report/pharmaceutical-analytical-testing-global-market-report

Which Region Is Forecasted To Lead The Pharmaceutical Analytical Testing Market In The Coming Years?

North America was the largest region in the pharmaceutical analytical testing market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the pharmaceutical analytical testing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Customize Your Report Here:

https://www.thebusinessresearchcompany.com/customise?id=27378&type=smp

Browse Through More Reports Similar to the Global Pharmaceutical Analytical Testing Market 2025, By The Business Research Company

Light Towers Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/light-towers-global-market-report

Electric Lighting Equipment Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/electric-lighting-equipment-global-market-report

Electric Light Commercial Vehicle Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/electric-light-commercial-vehicle-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20

What Is The Predicted Market Size Trajectory For The Pharmaceutical Analytical Testing Market From 2025 To 2034?

The pharmaceutical analytical testing market size has seen robust growth over recent years. It is anticipated to expand from $7.52 billion in 2024 to $8.21 billion in 2025, achieving a compound annual growth rate (CAGR) of 9.1%. The market’s past development can be attributed to an increase in generic drug approvals, greater investment by pharmaceutical firms, the expansion of biologics and biosimilars, advancements in personalized medicine, and a growing requirement for advanced testing methodologies.

The pharmaceutical analytical testing market is poised for significant expansion in the coming years. Projections indicate its value will reach $11.48 billion by 2029, demonstrating a compound annual growth rate (CAGR) of 8.7%. This anticipated growth during the forecast period is fueled by several factors, including the increasing demand for biologics, cell, and gene therapies, the expansion of pharmaceutical production facilities in developing regions, the escalating complexity of novel drug molecules, a notable increase in the outsourcing of analytical services to contract research organizations (CROs), and an expanding portfolio of drugs targeting orphan and rare diseases. Key trends anticipated during this period encompass the integration of artificial intelligence into data analysis, the implementation of real-time release testing (RTRT), the deployment of automation and robotics within quality control laboratories, the utilization of cloud-based laboratory information management systems, a broader adoption of automation and digitalization, and the incorporation of real-time analytics.

Unlock Your Free Sample Report for Exclusive Market Data:

https://www.thebusinessresearchcompany.com/sample.aspx?id=27378&type=smp

What Are The Top Growth Drivers Impacting The Pharmaceutical Analytical Testing Market Outlook?

Increased drug approvals and clinical trials are projected to fuel expansion within the pharmaceutical analytical testing market. These processes involve a regulated approach to evaluating novel medications for their safety and efficacy via clinical trials, culminating in formal approval from health bodies for general availability. The surge in drug approvals and trials stems from progress in precision medicine, which facilitates the creation of highly specific treatments designed for unique genetic profiles, enhancing both effectiveness and the probability of regulatory acceptance. Pharmaceutical analytical testing plays a crucial role in drug approvals and clinical trials because it guarantees the safety, effectiveness, and quality of pharmaceutical products by delivering validated information concerning stability, impurities, bioavailability, and pharmacokinetics, thereby aiding regulatory adherence and evidence-based choices. As an illustration, in November 2023, a report from the Association of the British Pharmaceutical Industry (ABPI), a non-profit organization based in the UK, indicated a marginal 4.3% increase in the total annual industry clinical trials commenced in the UK, moving from 394 trials in 2021 to 411 in 2022. Consequently, the uptick in drug approvals and trials is propelling the expansion of the pharmaceutical analytical testing market.

What Are The Major Segment Categories Driving The Pharmaceutical Analytical Testing Market Growth?

The pharmaceutical analytical testing market covered in this report is segmented

1) By Service Type: Bioanalytical Testing, Method Development And Validation, Stability Testing, Drug Substances Testing, Microbial Testing, Physical Characterization, Other Service Types

2) By Technique Used: Chromatography, Spectroscopy, Mass Spectrometry, Electrophoresis, Microscopy

3) By Application: Quality Control, Research And Development, Regulatory Compliance, Drug Approval And Registration, Post-Marketing Surveillance

4) By End User: Pharmaceutical Companies, Contract Research Organizations (CROs), Academic Institutions, Regulatory Bodies, Testing Laboratories

Subsegments:

1) By Bioanalytical Testing: Pharmacokinetics Testing, Biomarker Testing, Immunogenicity Testing, Toxicokinetics Testing

2) By Method Development And Validation: Analytical Method Development, Analytical Method Validation, Method Transfer

3) By Stability Testing: Long-Term Stability Testing, Accelerated Stability Testing, Stress Stability Testing, Photostability Testing

4) By Drug Substances Testing: Raw Material Testing, Intermediate Testing, Final Drug Substance Testing

5) By Microbial Testing: Bioburden Testing, Sterility Testing, Endotoxin Testing, Microbial Limit Testing

6) By Physical Characterization: Particle Size Analysis, Polymorphism Analysis, Rheology Testing, Thermal Analysis

7) By Other Service Types: Impurity Testing, Elemental Impurity Testing, Extractables And Leachables Testing, Packaging Testing

What Are The Major Trends Driving The Growth Of The Pharmaceutical Analytical Testing Market?

Major companies operating in the pharmaceutical analytical testing market are concentrating on introducing advanced solutions, such as digital reference materials platforms, to elevate the accuracy, traceability, and efficiency of laboratory testing processes, thereby ensuring regulatory compliance and enhancing overall data integrity. A digital reference materials platform is an online or software-based system that provides authenticated, standardized digital datasets or models used for calibrating, validating, and verifying analytical testing processes in pharmaceutical laboratories. For instance, in November 2023, Merck Group, a Germany-based pharmaceutical company, launched ChemisTwin, which is the first-ever digital reference materials platform designed for analytical testing. It automates the analysis of sample purity, compound identification, and degradation using calibrated, algorithm-based digital references. Featuring digital signatures for over 1,500 reference materials, ChemisTwin streamlines and accelerates workflows in pharmaceutical quality control, quality assurance, and research and development by offering traceable digital records linked to physical reference materials. This innovative platform reduces manual tasks such as weighing and documentation, boosts sampling rates, and improves the detection of sample inconsistencies, ultimately ensuring safer and more reliable products.

Which Industry Leaders Are Driving Innovation Across The Pharmaceutical Analytical Testing Market?

Major companies operating in the pharmaceutical analytical testing market are Thermo Fisher Scientific Inc., Merck KGaA, IQVIA Holdings Inc., Laboratory Corporation of America Holdings, Ajinomoto Co. Inc., ICON Public Limited Company, Eurofins Scientific SE, Pharmaceutical Product Development LLC, WuXi AppTec Co. Ltd., Syneos Health Inc., Steris plc, Catalent Inc., Charles River Laboratories International Inc., Intertek Group plc, AptarGroup Inc., West Pharmaceutical Services Inc., SGS Société Générale de Surveillance SA, Almac Group Limited, Pace Analytical Services LLC, Neotron S.p.A., Toxikon Corporation, Element Materials Technology Group Limited, and Boston Analytical Inc.

Download The Full Report For Exclusive Market Findings:

https://www.thebusinessresearchcompany.com/report/pharmaceutical-analytical-testing-global-market-report

Which Region Is Expected To Witness The Fastest Growth In The Pharmaceutical Analytical Testing Market?

North America was the largest region in the pharmaceutical analytical testing market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the pharmaceutical analytical testing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Version Of The Pharmaceutical Analytical Testing Market Report:

https://www.thebusinessresearchcompany.com/customise?id=27378&type=smp

Browse Through More Reports Similar to the Global Pharmaceutical Analytical Testing Market 2025, By The Business Research Company

Light Towers Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/light-towers-global-market-report

Portable Power Stations Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/portable-power-stations-global-market-report

Electric Lighting Equipment Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/electric-lighting-equipment-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

How Large Is the Pharmaceutical Analytical Testing Market Expected to Be in 2029?

The size of the pharmaceutical analytical testing market has seen significant expansion in the recent past. This market is projected to increase from $7.52 billion in 2024 to $8.21 billion in 2025, demonstrating a compound annual growth rate (CAGR) of 9.1%. The escalation during the historical period can be attributed to the increase in approvals for generic drugs, investments by pharmaceutical firms, growth of biologics and biosimilars, surge in personalized medicine, and mounting demand for sophisticated testing.

In the coming years, the pharmaceutical analytical testing market is set to experience robust growth. The market is projected to expand to $11.48 billion by 2029, at a Compound Annual Growth Rate (CAGR) of 8.7%. This anticipated growth within the forecast period can be linked to factors such as an increased demand for biologics as well as cell and gene therapies, the expansion of pharmaceutical manufacturing in developing markets, the heightened complexity of novel drug molecules, a rise in the outsourcing of analytical services to Contract Research Organizations (CROs), along with a growing pipeline of orphan drugs and rare disease therapies. Noteworthy trends within the forecast period encompass the incorporation of artificial intelligence in data analysis, real-time release testing (RTRT), the use of automation and robotics in Quality Control (QC) labs, the implementation of cloud-based laboratory information management systems, as well as the increasing acceptance of automation, digitalization and real-time analytics.

Download The Free Sample Report Here:

https://www.thebusinessresearchcompany.com/sample.aspx?id=27378&type=smp

What Are The Contributors To Demand In The Pharmaceutical Analytical Testing Market?

The increase in drug approvals and trials is predicted to foster the expansion of the pharmaceutical analytical testing market. Drug approvals and trials encompass the regulated procedure of examining new drugs’ safety and effectiveness through clinical trials, which is then followed by formal approval from health authorities for public use. The rise in these drug approvals and trials can be attributed to the progression of precision medicine, which enables the creation of highly personalized therapies based on genetic profiles, thus, boosting the chances of efficacy and regulatory success. Pharmaceutical analytical testing plays an indispensable role in drug approvals and clinical trials. It guarantees the safety, efficacy, and quality of drugs by delivering validated information on characteristics such as stability, impurities, bioavailability, and pharmacokinetics, aiding regulatory compliance and informed decision-making. For example, a report by the Association of the British Pharmaceutical Industry (ABPI), a non-profit association in the UK, indicated that the total annual number of industry clinical trials initiated in the UK grew modestly by 4.3%, which meant an increase from 394 trials in 2021 to 411 in 2022. Consequently, the upsurge in drug approvals and trials is contributing to the progression of the pharmaceutical analytical testing market.

What Segmentation Categories Are Included In The Pharmaceutical Analytical Testing Market Analysis?

The pharmaceutical analytical testing market covered in this report is segmented

1) By Service Type: Bioanalytical Testing, Method Development And Validation, Stability Testing, Drug Substances Testing, Microbial Testing, Physical Characterization, Other Service Types

2) By Technique Used: Chromatography, Spectroscopy, Mass Spectrometry, Electrophoresis, Microscopy

3) By Application: Quality Control, Research And Development, Regulatory Compliance, Drug Approval And Registration, Post-Marketing Surveillance

4) By End User: Pharmaceutical Companies, Contract Research Organizations (CROs), Academic Institutions, Regulatory Bodies, Testing Laboratories

Subsegments:

1) By Bioanalytical Testing: Pharmacokinetics Testing, Biomarker Testing, Immunogenicity Testing, Toxicokinetics Testing

2) By Method Development And Validation: Analytical Method Development, Analytical Method Validation, Method Transfer

3) By Stability Testing: Long-Term Stability Testing, Accelerated Stability Testing, Stress Stability Testing, Photostability Testing

4) By Drug Substances Testing: Raw Material Testing, Intermediate Testing, Final Drug Substance Testing

5) By Microbial Testing: Bioburden Testing, Sterility Testing, Endotoxin Testing, Microbial Limit Testing

6) By Physical Characterization: Particle Size Analysis, Polymorphism Analysis, Rheology Testing, Thermal Analysis

7) By Other Service Types: Impurity Testing, Elemental Impurity Testing, Extractables And Leachables Testing, Packaging Testing

What Upcoming Trends Are Expected To Impact The Pharmaceutical Analytical Testing Market Globally?

Leading businesses in the pharmaceutical analytical testing market are centering on launching inventive solutions like digital reference materials platforms to boost precision, traceability, and productivity of laboratory testing procedures, consequently guaranteeing regulatory adherence and superior data integrity. Essentially, a digital reference materials platform denotes a web-based or software-oriented system that offers certified, standardized digital datasets or models suitable for calibrating, validating, and corroborating analytical testing procedures in pharmaceutical labs. In November 2023, for example, the pharmaceutical company Merck Group from Germany, premiered ChemisTwin – the pioneer digital reference materials platform tailored for analytical testing that enhance the analysis of sample purity, compound recognition, and degradation via calibrated, algorithm-oriented digital references. With digital signatures for over 1,500 reference materials, ChemisTwin expedites and simplifies workflows in pharmaceutical quality control, quality assurance, and research and development by providing trackable digital records associated with physical reference materials. This advanced platform minimizes manual duties including weighing and documentation, enlarges sampling rates, and boosts detection of sample discrepancies, thereby delivering safer and more dependable products.

Who Are The Top-Ranked Companies In The Pharmaceutical Analytical Testing Market Today?

Major companies operating in the pharmaceutical analytical testing market are Thermo Fisher Scientific Inc., Merck KGaA, IQVIA Holdings Inc., Laboratory Corporation of America Holdings, Ajinomoto Co. Inc., ICON Public Limited Company, Eurofins Scientific SE, Pharmaceutical Product Development LLC, WuXi AppTec Co. Ltd., Syneos Health Inc., Steris plc, Catalent Inc., Charles River Laboratories International Inc., Intertek Group plc, AptarGroup Inc., West Pharmaceutical Services Inc., SGS Société Générale de Surveillance SA, Almac Group Limited, Pace Analytical Services LLC, Neotron S.p.A., Toxikon Corporation, Element Materials Technology Group Limited, and Boston Analytical Inc.

Get The Full Report Here:

https://www.thebusinessresearchcompany.com/report/pharmaceutical-analytical-testing-global-market-report

How Is Pharmaceutical Analytical Testing Market Adoption Varying Across Different Regions And Sectors?

North America was the largest region in the pharmaceutical analytical testing market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the pharmaceutical analytical testing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request For A Customized Report:

https://www.thebusinessresearchcompany.com/customise?id=27378&type=smp

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model